For the Inventor, By the Inventor

Enter assignee name

Virbac Corporation

Calculating rank

USPTO Granted Patents = 48

% Expired Patents = 12.5

CIPO Patents = 2

EPO Patents = 31

Trademarks = 63

Forward Citations = 210

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Guy Derrieu (8 out of 22 patents)

Michel Robin (7 out of 7 patents)

Thomas A Miller (4 out of 4 patents)

4. Laurent Rodrigues (3 out of 3 patents)

5. Arnaud Steiner (3 out of 3 patents)

6. Patricia Monginoux (3 out of 3 patents)

7. Fanny Martins (3 out of 3 patents)

8. Nathalie Delhom (3 out of 3 patents)

9. Bertrand Havrileck (3 out of 4 patents)

10. Albert Ahn (3 out of 14 patents)

11. Ian Cottrell (3 out of 21 patents)

12. Benoît Berny (2 out of 2 patents)

13. Jean-Michel Brunel (2 out of 8 patents)

14. Jean-Pascal Marc (2 out of 2 patents)

15. Nicolas Brunel (2 out of 2 patents)

Core Competencies:

Fluralaner

Modoflaner

Glucocorticoids

Anxiety Treatment

Anthelmintic Formulations

Topical Compositions

Veterinary Use

Squalamine Derivatives

Vaccine Composition

Behavioral Disorders

Nutritional Composition

Parasite Control

48 patents: Sort by Forward Citations

1. 12714696 - Low dose fluralaner compositions for protection against parasitic invertebrate pest (2026-08-25),

2. 12509425 - Tablet comprising modoflaner as an active component (2025-12-30),

3. 12478629 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2025-11-25),

4. 11819506 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2023-11-21),

5. 11752127 - Methods and compositions for treatment of anxiety in animals (2023-09-12),

6. 11628973 - Impact-protection device capable of being provided on a bottle (2023-04-18),

7. 11364175 - Device for collecting a sample of a liquid contained in a container, associated container, and use of this container (2022-06-21),

8. 11325748 - Impact-protection device capable of being provided on a bottle (2022-05-10),

9. 11266789 - Multi-dose dispenser (2022-03-08),

10. 10780101 - Amide derivatives of squalamine for the treatment of infections (2020-09-22),

11. 10729701 - Compounds that are analogs of squalamine, used as antibacterial agents (2020-08-04),

12. D878214 - Bottle protector (2020-03-17),

13. 10548867 - Soothing composition for animals, comprising at least one fatty acid and nepetalactone (2020-02-04),

14. 10493032 - Nutritional and medicinal oral composition for veterinary use (2019-12-03),

15. 10426840 - Oil suspension of metronidazole (2019-10-01),

Company Overview

Virbac Corporation is a global leader in veterinary pharmaceuticals, dedicated to improving animal health through innovative solutions. Headquartered in Carros, France, the company specializes in a diverse range of products, including glucocorticoids, topical compositions, and sustained release vaccines. Virbac's research focuses on addressing various veterinary needs, such as epithelial infections, anthelmintic formulations, and behavioral disorders, ensuring comprehensive care for animals worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

48 Patents

#1 in Carros

#491 in France

#14,575 in the World

Virbac Corporation

Forward Citations = 210

71 inventors:

Guy Derrieu (8 out of 22 patents)

Michel Robin (7 out of 7 patents)

Thomas A Miller (4 out of 4 patents)

4. Laurent Rodrigues (3 out of 3 patents)

5. Arnaud Steiner (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Virbac Corporation. Retrieved from https://idiyas.com/company/virbac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…